Asuragen Launches FNA Version of microRNA Pancreatic Cancer Diagnostic
February 23, 2012
Asuragen Launches FNA Version of microRNA Pancreatic Cancer Diagnostic
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Rosetta Publishes Data on Cancer of Unknown Primary Origin Test
May 31, 2012 / Gene Silencing News - After Medicare Nod for CUP Diagnostic, Rosetta Aims to Get Coverage for Other miRNA Tests
May 24, 2012 / Gene Silencing News - Rosetta Issued Notice of Allowance on microRNA Patent Application
April 26, 2012 / Gene Silencing News - Pfizer Researcher Says miRNA Markers Have Promise Beyond Oncology, but a Lengthy Development Runway
March 15, 2012 / Gene Silencing News - Asuragen Presents Data on miRNA Tests for Pancreatic Cancer
November 10, 2011 / Gene Silencing News